Recip

Recipharm is a leading global Contract Development and Manufacturing Organisation (CDMO) headquartered in Stockholm, Sweden. Established in 1995 as Recip AB, the company offers comprehensive services ranging from early-stage drug development to commercial-scale manufacturing and packaging. Their expertise spans a wide array of dosage forms, including oral solids, semi-solids, inhalers, and sterile injectables. Recipharm serves a global customer base of pharmaceutical and biotechnology companies, operating manufacturing and R&D facilities across Europe, North America, and Asia. In 2021, the company was acquired by the private equity firm EQT, transitioning from a public entity to a private one to further its international expansion and service capabilities.